CURE OM funds critically important research. People battling OM urgently need more treatment options. There is currently only one FDA-approved treatment for metastatic OM, which is only effective in a subset of patients. Research to advance new treatments is critical. Many people with OM choose to enter clinical trials where they’re able to access cutting-edge treatments. Participating in clinical trials contributes to research advancements that benefit the entire OM community. Researchers are learning more about the biology, genetics and natural history of OM, allowing them to explore new and promising treatments. The MRF offers grants to researchers through the CURE OM initiative in order to speed the pace of discovery. Continuous support of research is the only way to achieve the advances patients need. CURE OM sponsors its own patient-driven research initiative called Virtual Information System to Improve Outcomes and Networks (VISION), an IRB-approved natural history study that captures the patient journey. The intent of the research is to centralize and study patient data from around the world. By funding this critical research, the CURE OM initiative is accelerating treatment development to bring new therapies to people with OM. To learn more about CURE OM-funded research, visit cureom.org .
CURE OM puts patients at the center of research through the VISION Platform.
Made with FlippingBook Ebook Creator